Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Garvan Institute of Medical Research, New South Wales, Australia
School of Medical Sciences, University of New South Wales, New South Wales, Australia
Search for other papers by Vita Birzniece in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Department of Diabetes and Endocrinology, Westmead Hospital, New South Wales, Australia
Search for other papers by Teresa Lam in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Search for other papers by Mark McLean in
Google Scholar
PubMed
Search for other papers by Navneeta Reddy in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Search for other papers by Haleh Shahidipour in
Google Scholar
PubMed
Faculty of Medicine, Health and Human Sciences, Macquarie University, New South Wales, Australia
Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia
Search for other papers by Amy Hayden in
Google Scholar
PubMed
Search for other papers by Howard Gurney in
Google Scholar
PubMed
Search for other papers by Glenn Stone in
Google Scholar
PubMed
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Steno Diabetes Center Odense, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Search for other papers by Rikke Hjortebjerg in
Google Scholar
PubMed
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Search for other papers by Jan Frystyk in
Google Scholar
PubMed
hypogonadism, it is associated with the development of obesity, insulin resistance, hyperinsulinemia, and increased cardiovascular disease risk ( 1 , 2 ). The metabolic syndrome is present in >50% of men receiving long-term ADT compared to 20% of matched
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Nikolaos Kyriakakis in
Google Scholar
PubMed
Search for other papers by Marilena Giannoudi in
Google Scholar
PubMed
Search for other papers by Satish S Kumar in
Google Scholar
PubMed
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Khyatisha Seejore in
Google Scholar
PubMed
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Harpal Randeva in
Google Scholar
PubMed
Leeds Institute of Medical Research, University of Leeds, UK
Search for other papers by Adam Glaser in
Google Scholar
PubMed
Search for other papers by Michelle Kwok-Williams in
Google Scholar
PubMed
Search for other papers by Georgina Gerrard in
Google Scholar
PubMed
Search for other papers by Carmel Loughrey in
Google Scholar
PubMed
Search for other papers by Ahmed Al-Qaissi in
Google Scholar
PubMed
Search for other papers by Ramzi Ajjan in
Google Scholar
PubMed
Search for other papers by Julie Lynch in
Google Scholar
PubMed
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Robert D Murray in
Google Scholar
PubMed
8-h overnight fast was taken for measurement of serum lipid profile (total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglycerides) and glucose metabolism (serum insulin and glucose). Insulin sensitivity was calculated using the homeostatic
Search for other papers by Ruth Percik in
Google Scholar
PubMed
Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Search for other papers by Safwaan Adam in
Google Scholar
PubMed
Search for other papers by Kate Young in
Google Scholar
PubMed
Royal Marsden Hospital, London, UK
Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
pituitary hormones is required (TSH and free thyroxine (T4), luteinizing hormone, follicle-stimulating hormone, growth hormone, Prolactin, insulin-like growth factor 1, total testosterone for men and oestradiol for pre-menopausal women). Hypocortisolism
Search for other papers by Sonja Kunz in
Google Scholar
PubMed
Search for other papers by Xiao Wang in
Google Scholar
PubMed
Search for other papers by Uta Ferrari in
Google Scholar
PubMed
Search for other papers by Michael Drey in
Google Scholar
PubMed
Search for other papers by Marily Theodoropoulou in
Google Scholar
PubMed
Search for other papers by Katharina Schilbach in
Google Scholar
PubMed
Search for other papers by Martin Reincke in
Google Scholar
PubMed
KORA Study Centre, University Hospital of Augsburg, Augsburg, Augsburg, Germany
Search for other papers by Margit Heier in
Google Scholar
PubMed
German Centre for Cardiovascular Research (DZHK), Partner site Munich Heart Alliance, Munich, Germany
Search for other papers by Annette Peters in
Google Scholar
PubMed
German Heart Centre Munich, Technical University of Munich, Munich, Germany
Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
Search for other papers by Wolfgang Koenig in
Google Scholar
PubMed
German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany
Search for other papers by Tanja Zeller in
Google Scholar
PubMed
Search for other papers by Barbara Thorand in
Google Scholar
PubMed
Search for other papers by Martin Bidlingmaier in
Google Scholar
PubMed
. ( https://doi.org/10.1016/j.cca.2019.04.062 ) 37 Osuna JA Gómez-Pérez R Arata-Bellabarba G & Villaroel V . Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland
Search for other papers by Hanna Karhapää in
Google Scholar
PubMed
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland
Search for other papers by Siru Mäkelä in
Google Scholar
PubMed
Department of Radiology, HUS Medical Imaging Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Search for other papers by Hanna Laurén in
Google Scholar
PubMed
Department of Radiology, HUS Medical Imaging Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Search for other papers by Marjut Jaakkola in
Google Scholar
PubMed
Endocrinology, Abdominal Centre, University of Helsinki and HUS, Helsinki, Finland
Search for other papers by Camilla Schalin-Jäntti in
Google Scholar
PubMed
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland
Search for other papers by Micaela Hernberg in
Google Scholar
PubMed
%) Methylpredn. 2 (5%) 1 (2%) 0 (0%) 0 (0%) 1 (17%) Insulin 3 (7%) 1 (2%) 2 (3%) 0 (0%) 0 (0%) Thyroid AE 36 (82%) 9 (20%) 22 (33%) 2 (10%) 3 (50%) Grade 3–4 3 (7%) 1 (2%) 2 (3%) 0 (0%) 0 (0
Search for other papers by Anna Gorbacheva in
Google Scholar
PubMed
Search for other papers by Anna Eremkina in
Google Scholar
PubMed
Search for other papers by Daria Goliusova in
Google Scholar
PubMed
Search for other papers by Julia Krupinova in
Google Scholar
PubMed
Search for other papers by Natalia Mokrysheva in
Google Scholar
PubMed
Cancer Care 2017 26 e12740. ( https://doi.org/10.1111/ecc.12740 ) 10 Lu Z Chiu J Lee LR Schindeler A Jackson M Ramaswamy Y Dunstan CR Hogg PJ Zreiqat H . Reprogramming of human fibroblasts into osteoblasts by insulin-like growth
Faculty of Medicine Division 2, Internal Medicine Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands
Search for other papers by E K White in
Google Scholar
PubMed
Search for other papers by I V Wagner in
Google Scholar
PubMed
Faculty of Medicine Division 2, Internal Medicine Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands
Search for other papers by C van Beuzekom in
Google Scholar
PubMed
Search for other papers by V Iotova in
Google Scholar
PubMed
Department of Paediatrics, UMHAT ‘Sveta Marina’ Varna, Medical University of Varna, Varna, Bulgaria
Search for other papers by S F Ahmed in
Google Scholar
PubMed
Search for other papers by O Hiort in
Google Scholar
PubMed
Search for other papers by A M Pereira in
Google Scholar
PubMed
. Within Endo-ERN, eight different Main Thematic Groups (MTGs) are defined: MTG1 Adrenal; MTG2 Disorders of Calcium & Phosphate Homeostasis; MTG3 Genetic Disorders of Glucose & Insulin Homeostasis; MTG4 Genetic Endocrine Tumor Syndromes; MTG5 Growth
Search for other papers by Eleftherios E Deiktakis in
Google Scholar
PubMed
Search for other papers by Eleftheria Ieronymaki in
Google Scholar
PubMed
Search for other papers by Peter Zarén in
Google Scholar
PubMed
Search for other papers by Agnes Hagsund in
Google Scholar
PubMed
Search for other papers by Elin Wirestrand in
Google Scholar
PubMed
Search for other papers by Johan Malm in
Google Scholar
PubMed
Search for other papers by Christos Tsatsanis in
Google Scholar
PubMed
Imperial College London, Institute of Reproductive and Developmental Biology, London, UK
Search for other papers by Ilpo T Huhtaniemi in
Google Scholar
PubMed
Malmö University Hospital, Reproductive Medicine Center, Malmö, Sweden
Search for other papers by Aleksander Giwercman in
Google Scholar
PubMed
Search for other papers by Yvonne Lundberg Giwercman in
Google Scholar
PubMed
radical prostatectomy . Clinical Cancer Research 2017 23 1974 – 1980 . ( https://doi.org/10.1158/1078-0432.CCR-16-1790 ) 20 Roth MY Lin K Bay K Amory JK Anawalt BD Matsumoto AM Marck BT Bremner WJ Page ST . Serum insulin-like factor 3
Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands
Search for other papers by Josephina G Kuiper in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Search for other papers by Aline C Fenneman in
Google Scholar
PubMed
Search for other papers by Anne H van der Spek in
Google Scholar
PubMed
Search for other papers by Elena Rampanelli in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Search for other papers by Max Nieuwdorp in
Google Scholar
PubMed
Search for other papers by Myrthe P P van Herk-Sukel in
Google Scholar
PubMed
Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands
Search for other papers by Valery E P P Lemmens in
Google Scholar
PubMed
Search for other papers by Ernst J Kuipers in
Google Scholar
PubMed
Department of Epidemiology and Data Science, Amsterdam UMC, Amsterdam, Netherlands
Search for other papers by Ron M C Herings in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
that potentially decrease the risk of CRC including use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), statins, antidiabetics (both oral antidiabetics and insulin), hormone replacement therapy, and oral contraceptives. Non-users of